Performance Status Assessment by Using ECOG (Eastern Cooperative Oncology Group) Score for Cancer Patients by Oncology Healthcare Professionals

Faisal Azam, Muhammad Farooq Latif, Ayesha Farooq, Syed Hammad Tirmazy, Saad AlShahrani, Shahid Bashir, Nedal Bukhari, Faisal Azam, Muhammad Farooq Latif, Ayesha Farooq, Syed Hammad Tirmazy, Saad AlShahrani, Shahid Bashir, Nedal Bukhari

Abstract

Medical literature does not have clear consensus on inter-rater reliability of PS assessment by different oncology health care professionals (HCPs) although it plays an important role in treatment decision and prognosis for oncology patients. Eastern Cooperative Oncology Group (ECOG) and Karnofsky performance status (KPS) scores are commonly used for this purpose by oncology HCPs around the world. This study was conducted to find variability or similarities in assessment of PS among the different oncology HCPs. A survey based on four hypothetical clinical scenarios was devised and sent to 50 oncology HCPs to assess the PS using ECOG PS tool. No significant variations in PS assessment by oncology HCPs was noted in our study sample.

Keywords: Eastern Cooperative Oncology Group (ECOG); Karnofsky performance status (KPS); Performance status.

Conflict of interest statement

We declare that authors have no conflict of interest.

Copyright © 2019 by S. Karger AG, Basel.

Figures

Fig. 1
Fig. 1
Numbers of HCPs responses for the first scenario.
Fig. 2
Fig. 2
Questionnaire with clinical scenarios used for the study.
Fig. 3
Fig. 3
Numbers of HCPs responses for the second scenario.
Fig. 4
Fig. 4
Numbers of HCPs responses for the third scenario.
Fig. 5
Fig. 5
Numbers of HCPs responses for the fourth scenario.

References

    1. Karnofsky David A, Walter H, Abelmann, Lloyd F, Burchenal Craver Joseph H, The use of the nitrogen mustards in the palliative treatment of carcinoma With particular reference to bronchogenic carcinoma. Cancer. 1948 Nov;1((4)):634–56.
    1. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982 Dec;5((6)):649–55.
    1. Anderson F, Downing GM, Hill J, Casorso L, Lerch N. Palliative performance scale (PPS): a new tool. J Palliat Care. 1996;12((1)):5–11.
    1. Ciara M. Kelly, Armin Shahrokni, Moving beyond Karnofsky and ECOG Performance Status Assessments with New Technologies. J Oncol. 2016 Mar;2016((3)):1–13.
    1. Taylor AE, Olver IN, Sivanthan T, Chi M, Purnell C. Observer error in grading performance status in cancer patients. Support Care Cancer. 1999 Sep;7((5)):332–5.
    1. Campos S, Zhang L, Sinclair E, Tsao M, Barnes EA, Danjoux C, et al. The palliative performance scale: examining its inter-rater reliability in an outpatient palliative radiation oncology clinic. Support Care Cancer. 2009 Jun;17((6)):685–90.
    1. Blagden SP, Charman SC, Sharples LD, Magee LR, Gilligan D. Performance status score: do patients and their oncologists agree? Br J Cancer. 2003 Sep;89((6)):1022–7.
    1. Kim YJ, Hui D, Zhang Y. Difference in performance status assessments between palliative care specialists, nurses and oncologists. J Pain Symptom Manage, 2015;49:1050–1058. e2. 26.
    1. May CH, Lester JF, Lee S. PS score discordance and why it matters. Lung Cancer. 2012;75:S18.
    1. Zimmermann C, Burman D, Bandukwala S, Seccareccia D, Kaya E, Bryson J, et al. Nurse and physician inter-rater agreement of three performance status measures in palliative care outpatients. Support Care Cancer. 2010 May;18((5)):609–16.
    1. Campos S, Zhang L, Sinclair E, Tsao M, Barnes EA, Danjoux C, et al. The palliative performance scale: examining its inter-rater reliability in an outpatient palliative radiation oncology clinic. Support Care Cancer. 2009 Jun;17((6)):685–90.
    1. Sørensen JB, Klee M, Palshof T, Hansen HH. Performance status assessment in cancer patients. An inter-observer variability study. Br J Cancer. 1993 Apr;67((4)):773–5.
    1. Roila F, Lupattelli M, Sassi M, Basurto C, Bracarda S, Picciafuoco M, et al. Intra and interobserver variability in cancer patients' performance status assessed according to Karnofsky and ECOG scales. Ann Oncol. 1991 Jun;2((6)):437–9.
    1. Liem BJ, Holland JM, Kang MY, Hoffelt SC, Marquez CM. Karnofsky Performance Status assessment: resident versus attending. J Cancer Educ. 2002;17((3)):138–41.
    1. Chow R, Chiu N, Bruera E, Krishnan M, Chiu L, Lam H, et al. Inter-rater reliability in performance status assessment among health care professionals: a systematic review. Ann Palliat Med. 2016 Apr;5((2)):83–92.
    1. de Borja MT, Chow E, Bovett G, Davis L, Gillies C. The correlation among patients and health care professionals in assessing functional status using the karnofsky and eastern cooperative oncology group performance status scales. Support Cancer Ther. 2004 Oct;2((1)):59–63.
    1. Conill C, Verger E, Salamero M. Performance status assessment in cancer patients. Cancer. 1990 Apr;65((8)):1864–6.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅